Question 1

Does BNP Paribas Financial Markets own VNDA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BNP Paribas Financial Markets holds 17,029 shares of VNDA (Vanda Pharmaceuticals), worth $104,217.

Question 2

How many shares of VNDA does BNP Paribas Financial Markets own?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Financial Markets holds 17,029 shares of VNDA (Vanda Pharmaceuticals).

Question 3

What is BNP Paribas Financial Markets' VNDA position worth?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Financial Markets' VNDA position is worth $104,217.

Question 4

Is BNP Paribas Financial Markets buying or selling VNDA?

Accepted Answer

In Q2 2026, BNP Paribas Financial Markets increased its VNDA position by 534 shares (+3.2%).

Question 5

When did BNP Paribas Financial Markets first buy VNDA?

Accepted Answer

BNP Paribas Financial Markets already held VNDA in its Q4 2018 13F, the earliest on record, and has listed it in 31 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	17,029	+3.2%	$104,217	0.0%	$6.12	15
2026-Q1	Increased	16,495	+3.8%	$113,980	0.0%	$6.91	23
2025-Q4	Decreased	15,891	-75.8%	$140,159	0.0%	$8.82	0
2025-Q3	Increased	65,535	+629.9%	$327,020	0.0%	$4.99	38
2025-Q2	Decreased	8,979	-72.1%	$42,381	0.0%	$4.72	0
2025-Q1	Decreased	32,180	-55.5%	$147,706	0.0%	$4.59	0
2024-Q4	Increased	72,312	+16.2%	$346,374	0.0%	$4.79	27
2024-Q3	Increased	62,238	+1184.6%	$291,896	0.0%	$4.69	38

VNDAShowing 8 of 31 quarters

VNDA
Showing 8 of 31 quarters